Kidney Cancer section

Kidney Cancer News & Features

Progression-free Survival in Advanced Renal Cell Carcinoma Is Improved With Cabozantinib

Findings of the randomized, phase 3 METEOR trial demonstrate progression-free survival in patients with advanced renal cell carcinoma is improved with cabozantinib compared with everolimus.

Study Evaluates Effect of Everolimus-induced Stomatitis

Study Evaluates Effect of Everolimus-induced Stomatitis

Everolimus-induced stomatitis did not negatively affect progression-free survival in patients with various types of cancer, such as breast cancer and renal cell carcinoma.

ASCO: Cabozantinib Increases Progression-Free Survival in RCC

ASCO: Cabozantinib Increases Progression-Free Survival in RCC

Improvements to progression-free survival (PFS) seen across patient subgroups treated with cabozantinib.

Nivolumab Now FDA Approved for Advanced RCC

Nivolumab Now FDA Approved for Advanced RCC

This newly approved drug operates by targeting the PD-1/PD-L1 cellular pathway.

Diabetes Linked to Worse Survival in Renal Cell Carcinoma

Diabetes Linked to Worse Survival in Renal Cell Carcinoma

For patients with diabetes, poor glycemic control is linked to higher risk of postoperative progression.

Kidney Cancer Videos

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs